The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 23, 2016
Filed:
Aug. 20, 2012
Casey C. Mccomas, Phoenixville, PA (US);
Nigel J. Liverton, Harleysville, PA (US);
Joerg Habermann, Munich, DE;
Uwe Koch, Dortmund, DE;
Frank Narjes, Kullavik, SE;
Peng LI, Shanghai, CN;
Xuanjia Peng, Shanghai, CN;
Richard Soll, San Diego, CA (US);
Hao Wu, Shanghai, CN;
Anandan Palani, Bridgewater, NJ (US);
Shuwen He, Edison, NJ (US);
Xing Dai, Cranford, NJ (US);
Hong Liu, Hillsborough, NJ (US);
Zhong Lai, East Brunswick, NJ (US);
Clare London, Chatham, NJ (US);
Dong Xiao, Warren, NJ (US);
Nicolas Zorn, Fanwood, NJ (US);
Ravi Nargund, East Brunswick, NJ (US);
Casey C. McComas, Phoenixville, PA (US);
Nigel J. Liverton, Harleysville, PA (US);
Joerg Habermann, Munich, DE;
Uwe Koch, Dortmund, DE;
Frank Narjes, Kullavik, SE;
Peng Li, Shanghai, CN;
Xuanjia Peng, Shanghai, CN;
Richard Soll, San Diego, CA (US);
Hao Wu, Shanghai, CN;
Anandan Palani, Bridgewater, NJ (US);
Shuwen He, Edison, NJ (US);
Xing Dai, Cranford, NJ (US);
Hong Liu, Hillsborough, NJ (US);
Zhong Lai, East Brunswick, NJ (US);
Clare London, Chatham, NJ (US);
Dong Xiao, Warren, NJ (US);
Nicolas Zorn, Fanwood, NJ (US);
Ravi Nargund, East Brunswick, NJ (US);
Merck Sharp & Dohme Corp., Rahway, NJ (US);
MSD Italia S.R.L., Rome, IT;
Abstract
The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.